ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 91 filers reported holding ADICET BIO INC in Q1 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $167,574 | +38.1% | 122,317 | +145.0% | 0.00% | – |
| Q2 2023 | $121,303 | -94.0% | 49,919 | -85.8% | 0.00% | – |
| Q1 2023 | $2,030,843 | -45.7% | 352,577 | -15.7% | 0.00% | -100.0% |
| Q4 2022 | $3,739,137 | -11.5% | 418,248 | +40.8% | 0.00% | 0.0% |
| Q3 2022 | $4,225,000 | +121.9% | 297,127 | +127.8% | 0.00% | – |
| Q2 2022 | $1,904,000 | -17.6% | 130,441 | +12.8% | 0.00% | – |
| Q1 2022 | $2,310,000 | +39.8% | 115,675 | +22.5% | 0.00% | – |
| Q4 2021 | $1,652,000 | +365.4% | 94,448 | +232.3% | 0.00% | – |
| Q1 2021 | $355,000 | – | 28,422 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 1,615,385 | $20,968,000 | 7.24% |
| Consonance Capital Management LP | 1,216,860 | $15,917,000 | 1.70% |
| VR Adviser, LLC | 1,000,000 | $13,080,000 | 1.42% |
| Johnson & Johnson Innovation - JJDC, Inc. | 728,944 | $9,535,000 | 1.24% |
| DAFNA Capital Management LLC | 385,077 | $5,037,000 | 1.20% |
| Ally Bridge Group (NY) LLC | 425,000 | $5,559,000 | 1.07% |
| Orbimed Advisors | 7,232,856 | $94,606,000 | 0.88% |
| Avidity Partners Management LP | 2,230,000 | $29,168,000 | 0.81% |
| Altium Capital Management LP | 142,289 | $1,861,000 | 0.52% |
| Nantahala Capital Management | 395,875 | $5,178,000 | 0.15% |